Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18360822rdf:typepubmed:Citationlld:pubmed
pubmed-article:18360822lifeskim:mentionsumls-concept:C0029132lld:lifeskim
pubmed-article:18360822lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:18360822lifeskim:mentionsumls-concept:C1417953lld:lifeskim
pubmed-article:18360822lifeskim:mentionsumls-concept:C0015295lld:lifeskim
pubmed-article:18360822pubmed:issue5lld:pubmed
pubmed-article:18360822pubmed:dateCreated2008-5-20lld:pubmed
pubmed-article:18360822pubmed:abstractTextA new c.740G>A (R247H) mutation in OPA1 alternate spliced exon 5b was found in a patient presenting with bilateral optic neuropathy followed by partial, spontaneous visual recovery. R247H fibroblasts from the patient and his unaffected father presented unusual highly tubular mitochondrial network, significant increased susceptibility to apoptosis, oxidative phosphorylation uncoupling, and altered OPA1 protein profile, supporting the pathogenicity of this mutation. These results suggest that the clinical spectrum of the OPA1-associated optic neuropathies may be larger than previously described, and that spontaneous recovery may occur in cases harboring an exon 5b mutation.lld:pubmed
pubmed-article:18360822pubmed:languageenglld:pubmed
pubmed-article:18360822pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18360822pubmed:citationSubsetIMlld:pubmed
pubmed-article:18360822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18360822pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18360822pubmed:statusMEDLINElld:pubmed
pubmed-article:18360822pubmed:monthMaylld:pubmed
pubmed-article:18360822pubmed:issn1531-8249lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:WallaceDougla...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:MullerAgnèsAlld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:DelettreCécil...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:LenaersGuyGlld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:BonneauDomini...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:GueguenNaïgNlld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:ReynierPascal...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:LoiseauDomini...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:ChevrollierAr...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:MileaDanDlld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:ProcaccioVinc...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:HamelChristia...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:Amati-Bonneau...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:FerréMarcMlld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:GuilletVirgin...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:CornilleKaren...lld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:ZazounLydieLlld:pubmed
pubmed-article:18360822pubmed:authorpubmed-author:El...lld:pubmed
pubmed-article:18360822pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18360822pubmed:volume63lld:pubmed
pubmed-article:18360822pubmed:ownerNLMlld:pubmed
pubmed-article:18360822pubmed:authorsCompleteYlld:pubmed
pubmed-article:18360822pubmed:pagination667-71lld:pubmed
pubmed-article:18360822pubmed:meshHeadingpubmed-meshheading:18360822...lld:pubmed
pubmed-article:18360822pubmed:meshHeadingpubmed-meshheading:18360822...lld:pubmed
pubmed-article:18360822pubmed:meshHeadingpubmed-meshheading:18360822...lld:pubmed
pubmed-article:18360822pubmed:meshHeadingpubmed-meshheading:18360822...lld:pubmed
pubmed-article:18360822pubmed:meshHeadingpubmed-meshheading:18360822...lld:pubmed
pubmed-article:18360822pubmed:meshHeadingpubmed-meshheading:18360822...lld:pubmed
pubmed-article:18360822pubmed:meshHeadingpubmed-meshheading:18360822...lld:pubmed
pubmed-article:18360822pubmed:meshHeadingpubmed-meshheading:18360822...lld:pubmed
pubmed-article:18360822pubmed:year2008lld:pubmed
pubmed-article:18360822pubmed:articleTitleReversible optic neuropathy with OPA1 exon 5b mutation.lld:pubmed
pubmed-article:18360822pubmed:affiliationInstitut National de la Santé et de la Recherche Médicale U583, Institut des Neurosciences de Montpellier, Université de Montpellier I et II, Montpellier, France.lld:pubmed
pubmed-article:18360822pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18360822pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:18360822pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:4976entrezgene:pubmedpubmed-article:18360822lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18360822lld:entrezgene
lhgdn:association:28926lhgdn:found_inpubmed-article:18360822lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18360822lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18360822lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18360822lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18360822lld:pubmed